About Alantis Sciences
Alantis Sciences is a company based in Manipal (India) founded in 2020 by K Satyamoorthy and Manesh Thomas. Alantis Sciences operates in a competitive market with competitors including Novogene Corporation, Access Bio, SD Biosensor, Rejuvenate Bio and Source BioScience, among others.
- Headquarter Manipal, India
- Founders K Satyamoorthy, Manesh Thomas
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website alantissciencesindia.com
- Legal Name Alantis Sciences India Private Limited
- Date of Incorporation 18 Feb, 2020
- Jurisdiction Manipal, Karnataka, India
- Annual Revenue₹12 Lakh
FY 2024 · -64% YoY
- Net Profit₹16,793
FY 2024 · 1% margin
- EBITDA₹1.5 Lakh
FY 2024 · 12% margin
Associated legal entities of Alantis Sciences
Alantis Sciences operates through Alantis Sciences India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Alantis Sciences India Private Limited CIN U85300KA2020PTC132773 | Active | 18 Feb 2020 | Manipal, Karnataka | ₹0.1 Cr | – | 2 | View details |
Board of directors of Alantis Sciences India Private Limited (Alantis Sciences)
Alantis Sciences India Private Limited is the primary company behind Alantis Sciences. The board of Alantis Sciences India Private Limited currently have 2 directors; the longest-serving is Manesh Thomas, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manesh Thomas DIN 06992650 | Director | 18 Feb 2020 | 6 yrs 7 mo | Alantis Sciences India Private Limited |
| Kapaettu Satyamoorthy DIN 08695172 | Director | 18 Feb 2020 | 6 yrs 7 mo | Alantis Sciences India Private Limited |
People of Alantis Sciences
2 people are tracked at Alantis Sciences (2 in leadership).
| Name | Role | Group |
|---|---|---|
K Satyamoorthy | Co-Founder | Leadership |
| Co-Founder | Leadership |
Complete people profiles for Alantis Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Alantis Sciences
Figures of Alantis Sciences India Private Limited, the primary company behind Alantis Sciences, for FY 2024. Revenue was ₹12 Lakh (-64% year on year). Net profit was ₹16,793 (1% margin). EBITDA was ₹1.5 Lakh (12% margin). Revenue has grown at a compounded annual rate of -26% over three years.
- ₹12 LakhRevenue · FY 2024 · -64% YoY
- ₹16,793Net profit · 1% margin
- ₹1.5 LakhEBITDA · 12% margin
- ₹1 LakhPaid-up capital
- -26%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Alantis Sciences India Private Limited are on its company page.
Detailed financial statements for Alantis Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Alantis Sciences
Alantis Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Access Bio, SD Biosensor, Rejuvenate Bio and Source BioScience, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| accessbio.net | 2001 | Somerset, United States | $22M | 52 | In vitro rapid diagnostic tests, biosensor, and molecular diagnostic products for diagnosis of infectious diseases. | |
| sdbiosensor.com | 2001 | Suwon-si, South Korea | – | – | Biosensors for point-of-care diagnostics are developed by SD Biosensor. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| sourcebioscience.com | 1903 | Nottingham, United Kingdom | – | 273 | Multiple genomic services are provided for analysis and diagnostics. | |
| basecare.cn | 2010 | Suzhou, China | $36.52M | – | NGS-based diagnostic solutions for neonatal screening are developed. | |
| lumosdiagnostics.com | 2017 | Carlsbad, United States | $40M | – | Diversified diagnostic assays and readers are developed for point-of-care use. | |
| macrogen.com | 1997 | Seoul, South Korea | – | – | Next-generation sequencing and genomics services are provided globally. | |
| mgrc.com.my | 2004 | Kuala Lumpur, Malaysia | – | – | Genome sequencing, analysis, and genetic screening services are provided. | |
| enarabio.com | 2016 | Oxford, United Kingdom | $84.05M | 38 | T-cell interfaces for cancer therapeutics are developed. |
Detailed competitors of Alantis Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Alantis Sciences
10 companies that operate in the same segment as Alantis Sciences (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Alantis Sciences
Alantis Sciences was founded in 2020.
Alantis Sciences is headquartered in Manipal, India. It is registered at Manipal, Karnataka, India.
The primary company behind Alantis Sciences, Alantis Sciences India Private Limited, reported revenue of ₹12 Lakh for FY 2024, down 64% year on year.
Alantis Sciences was founded in 2020 and is based in Manipal, India. Operations focus on the biotechnology sector, where molecular biology and microbiology research services are delivered. Rapid diagnostic tests for human diseases including Malaria, Leptospirosis, and Tuberculosis are developed. Additional offerings encompass diagnostic tests, genetic screening, bioinformatics support, and customized research and development solutions for diverse industries.
Alantis Sciences's top competitors include Novogene Corporation, Source BioScience and Access Bio.
Alantis Sciences operates through Alantis Sciences India Private Limited.
The legal entities of Alantis Sciences currently have 2 directors, including Manesh Thomas, Kapaettu Satyamoorthy.